| A FADD-dependent innate immune mechanism in mammalian cells S Balachandran, E Thomas, GN Barber Nature 432 (7015), 401-405, 2004 | 363 | 2004 |
| HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons E Thomas, VD Gonzalez, Q Li, AA Modi, W Chen, M Noureddin, Y Rotman, ... Gastroenterology 142 (4), 978-988, 2012 | 305 | 2012 |
| 17‐beta hydroxysteroid dehydrogenase 13 is a hepatic retinol dehydrogenase associated with histological features of nonalcoholic fatty liver disease Y Ma, OV Belyaeva, PM Brown, K Fujita, K Valles, S Karki, YS de Boer, ... Hepatology 69 (4), 1504-1519, 2019 | 210 | 2019 |
| Hepatitis C pharmacogenetics: state of the art in 2010 NH Afdhal, JG McHutchison, S Zeuzem, A Mangia, JM Pawlotsky, ... Hepatology 53 (1), 336-345, 2011 | 195 | 2011 |
| Ribavirin potentiates interferon action by augmenting interferon‐stimulated gene induction in hepatitis C virus cell culture models E Thomas, JJ Feld, Q Li, Z Hu, MW Fried, TJ Liang Hepatology 53 (1), 32-41, 2011 | 175 | 2011 |
| Kupffer cell and interleukin‐12–dependent loss of natural killer T cells in hepatosteatosis M Kremer, E Thomas, RJ Milton, AW Perry, N van Rooijen, MD Wheeler, ... Hepatology 51 (1), 130-141, 2010 | 174 | 2010 |
| The application and mechanism of action of ribavirin in therapy of hepatitis C E Thomas, MG Ghany, TJ Liang Antiviral Chemistry and Chemotherapy 23 (1), 1-12, 2012 | 154 | 2012 |
| Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: a longitudinal analysis M Noureddin, EC Wright, HJ Alter, S Clark, E Thomas, R Chen, X Zhao, ... Hepatology 58 (5), 1548-1557, 2013 | 143 | 2013 |
| Direct, interferon-independent activation of the CXCL10 promoter by NF-κB and interferon regulatory factor 3 during hepatitis C virus infection J Brownell, J Bruckner, J Wagoner, E Thomas, YM Loo, M Gale Jr, ... Journal of virology 88 (3), 1582-1590, 2014 | 132 | 2014 |
| Integrative functional genomics of hepatitis C virus infection identifies host dependencies in complete viral replication cycle Q Li, YY Zhang, S Chiu, Z Hu, KH Lan, H Cha, C Sodroski, F Zhang, ... PLoS pathogens 10 (5), e1004163, 2014 | 97 | 2014 |
| Experimental models of hepatitis B and C—new insights and progress E Thomas, TJ Liang Nature reviews Gastroenterology & hepatology 13 (6), 362-374, 2016 | 92 | 2016 |
| S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonresponders JJ Feld, AA Modi, R El–Diwany, Y Rotman, E Thomas, G Ahlenstiel, ... Gastroenterology 140 (3), 830-839. e3, 2011 | 81 | 2011 |
| Viral hepatitis: past and future of HBV and HDV E Thomas, M Yoneda, ER Schiff Cold Spring Harbor perspectives in medicine 5 (2), a021345, 2015 | 76 | 2015 |
| Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C Y Rotman, M Noureddin, JJ Feld, J Guedj, M Witthaus, H Han, YJ Park, ... Gut 63 (1), 161-169, 2014 | 67 | 2014 |
| Supersonic shear imaging and transient elastography with the XL probe accurately detect fibrosis in overweight or obese patients with chronic liver disease M Yoneda, E Thomas, SN Sclair, TT Grant, ER Schiff Clinical Gastroenterology and Hepatology 13 (8), 1502-1509. e5, 2015 | 56 | 2015 |
| Hepatitis B virus and DNA stimulation trigger a rapid innate immune response through NF-κB M Yoneda, J Hyun, S Jakubski, S Saito, A Nakajima, ER Schiff, E Thomas The Journal of Immunology 197 (2), 630-643, 2016 | 52 | 2016 |
| Differentiation of hepatocyte-like cells from human pluripotent stem cells using small molecules FZ Asumda, KE Hatzistergos, DM Dykxhoorn, S Jakubski, J Edwards, ... Differentiation 101, 16-24, 2018 | 47 | 2018 |
| SARS-CoV-2 and variant diagnostic testing approaches in the United States E Thomas, S Delabat, YL Carattini, DM Andrews Viruses 13 (12), 2492, 2021 | 42 | 2021 |
| HIV and HCV augments inflammatory responses through increased TREM-1 expression and signaling in Kupffer and Myeloid cells J Hyun, RS McMahon, AL Lang, JS Edwards, AD Badilla, ME Greene, ... PLoS pathogens 15 (7), e1007883, 2019 | 38 | 2019 |
| The influence of menopause on the development of hepatic fibrosis in nonobese women with nonalcoholic fatty liver disease M Yoneda, E Thomas, Y Sumida, Y Eguchi, ER Schiff Hepatology 60 (5), 1792, 2014 | 33 | 2014 |
T. Jake LiangNIHVerified email at nih.gov
